Five criteria to use when selecting a CRO for a gene therapy study

With cell and gene therapies (CGT) quickly making their way from theory to clinical practice, many biopharmaceutical companies are looking for CRO partners with significant experience conducting CGT-focused clinical studies. In this white paper, QPS describes five criteria to consider when evaluating organizations.